Zynerba Pharmaceuticals, Inc.

CIK 1621443 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Zynerba Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Feb 8, 2024SC 13G/A0000935836-24-000116
Oct 19, 202315-12G0001140361-23-048880
Oct 11, 202340001140361-23-047729
Oct 11, 2023S-8 POS0001140361-23-047700
Oct 11, 202325-NSE0001354457-23-000735
Oct 11, 202340001140361-23-047742
Oct 11, 2023S-8 POS0001140361-23-047710
Oct 11, 2023S-8 POS0001140361-23-047701
Oct 11, 202340001140361-23-047722
Oct 11, 2023SC 14D9/A0001140361-23-047695
Oct 11, 202340001140361-23-047727
Oct 11, 2023SC TO-T/A0001140361-23-047691
Oct 11, 2023S-8 POS0001140361-23-047713
Oct 11, 2023S-8 POS0001140361-23-047709
Oct 11, 202340001140361-23-047746
Oct 11, 202340001140361-23-047735
Oct 11, 202340001140361-23-047725
Oct 11, 2023EFFECT9999999995-23-002969
Oct 11, 202340001140361-23-047733
Oct 11, 202340001140361-23-047723
Oct 11, 2023S-8 POS0001140361-23-047718
Oct 11, 2023S-8 POS0001140361-23-047707
Oct 11, 2023S-8 POS0001140361-23-047703
Oct 11, 202340001140361-23-047743
Oct 11, 2023S-8 POS0001140361-23-047715